Skip to main content
Clinical Trials/JPRN-UMIN000024667
JPRN-UMIN000024667
Completed
未知

Effect of canagliflozin on endothelial function in patients with type 2 diabetes - Effect of canagliflozin on endothelial function in patients with type 2 diabetes

Medical Center for Translational and Clinical Research, Hiroshima University Hospital0 sites6 target enrollmentDecember 1, 2016
ConditionsType 2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Medical Center for Translational and Clinical Research, Hiroshima University Hospital
Enrollment
6
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medical Center for Translational and Clinical Research, Hiroshima University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Has history of hypersensitivity to Canagliflozin 2\. Has history of administration of SGLT2 inhibitor within 4 weeks before initiation of the study 3\.patient with insulin dependent diabetes mellitus 4\. Has history of myocardial infarction, angina, cerebral infarction, intracranial hemorrhage, subarachnoid hemorrhage, transient ischemic attacks within 3 months before initiation of the study 5\. patient with ASO 6\. With severe renal dysfunction (eGRF \<45 mL/min or patient undergoing artificial dialysis) 7\. Has history of severe ketosis, diabetic coma, or precoma within 6 months 8\. Has history of cancer, severe infection 9\. Pregnant, possibly pregnant, planned to become pregnant or nursing women 10\. Are considered not eligible for the study by the attending doctor due to other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials